The best-fit initial target cell concentration was ~16 cells μL-1, which corresponds to ~3% of the baseline CD4 T-cell count in blood (median 654 cells μL-1; ref [14]), again consistent with ~5% of the CD4 T-cells in blood expressing CCR5 [52], required for SIVmac251 infection. The gene discussed is CD4; the disease is infection.